ES405663A1 - Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina. - Google Patents

Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.

Info

Publication number
ES405663A1
ES405663A1 ES405663A ES405663A ES405663A1 ES 405663 A1 ES405663 A1 ES 405663A1 ES 405663 A ES405663 A ES 405663A ES 405663 A ES405663 A ES 405663A ES 405663 A1 ES405663 A1 ES 405663A1
Authority
ES
Spain
Prior art keywords
pyrazola
xanthine oxidase
compounds useful
oxidase inhibitors
pyrimidine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES405663A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Pharmaceuticals International Inc USA
Original Assignee
International Chemical and Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Chemical and Nuclear Corp filed Critical International Chemical and Nuclear Corp
Publication of ES405663A1 publication Critical patent/ES405663A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES405663A 1971-08-16 1972-08-08 Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina. Expired ES405663A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17219571A 1971-08-16 1971-08-16
US261103A US3920652A (en) 1971-08-16 1972-06-08 Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors

Publications (1)

Publication Number Publication Date
ES405663A1 true ES405663A1 (es) 1976-01-16

Family

ID=26867834

Family Applications (1)

Application Number Title Priority Date Filing Date
ES405663A Expired ES405663A1 (es) 1971-08-16 1972-08-08 Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.

Country Status (19)

Country Link
US (1) US3920652A (de)
JP (1) JPS4834899A (de)
AR (1) AR193536A1 (de)
AT (1) AT330780B (de)
BE (1) BE786611A (de)
BG (1) BG19806A3 (de)
DD (1) DD99581A5 (de)
DE (1) DE2236987A1 (de)
ES (1) ES405663A1 (de)
FR (1) FR2150771B1 (de)
GB (1) GB1359563A (de)
HU (1) HU167466B (de)
IE (1) IE36629B1 (de)
IL (1) IL39988A0 (de)
LU (1) LU65892A1 (de)
MC (1) MC937A1 (de)
NL (1) NL7211011A (de)
RO (1) RO63871A (de)
SU (1) SU522800A3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093617A (en) * 1974-11-12 1978-06-06 Icn Pharmaceuticals, Inc. 3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
US4048184A (en) * 1976-11-15 1977-09-13 E. R. Squibb & Sons, Inc. 6-Phenyl-2H-pyrazolo[3,4-b]pyridines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
KR927003595A (ko) * 1990-10-09 1992-12-18 오츠카 아키히코 피리미딘 유도체, 이의 제조방법 및 안드로겐 저해제
AU667575B2 (en) * 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
CA2206080A1 (en) * 1995-09-28 1997-04-03 Otsuka Pharmaceutical Factory, Inc. Analgesic composition_of pryazolo{1,5-a}pyrimidine derivatives
US6664261B2 (en) * 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
US7094782B1 (en) * 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
RO121272B1 (ro) * 1996-07-24 2007-02-28 The Du Pont Merck Pharmaceutical Company Azolotriazine şi pirimidine
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6235741B1 (en) * 1997-05-30 2001-05-22 Merck & Co., Inc. Angiogenesis inhibitors
AU1520699A (en) 1997-11-07 1999-05-31 Johns Hopkins University, The Methods for treatment of disorders of cardiac contractility
US6380203B1 (en) * 1998-01-14 2002-04-30 Merck & Co., Inc. Angiogenesis inhibitors
WO2000059907A2 (en) * 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
AU4203500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
DE112015002679T5 (de) 2014-06-06 2017-04-20 Siemens Medical Solutions Usa, Inc. Gammakamera-totzeitbestimmung in echtzeit unter verwendung langlebiger radioisotope

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048587A (en) * 1960-10-17 1962-08-07 Ortho Pharma Corp 2-alkylamino-4-aminopyrimidine
US3296268A (en) * 1965-10-19 1967-01-03 Searle & Co 3-cyanoethyl-2-oxo-5-phenyl [1, 5-a] pyrimidines

Also Published As

Publication number Publication date
ATA677372A (de) 1975-10-15
RO63871A (fr) 1979-01-15
IE36629B1 (en) 1977-01-19
DD99581A5 (de) 1973-08-12
AR193536A1 (es) 1973-04-30
DE2236987A1 (de) 1973-03-01
FR2150771A1 (de) 1973-04-13
FR2150771B1 (de) 1976-05-21
IL39988A0 (en) 1972-09-28
US3920652A (en) 1975-11-18
GB1359563A (en) 1974-07-10
IE36629L (en) 1973-02-16
NL7211011A (de) 1973-02-20
JPS4834899A (de) 1973-05-22
SU522800A3 (ru) 1976-07-25
HU167466B (de) 1975-10-28
BE786611A (fr) 1973-01-22
LU65892A1 (de) 1973-01-15
AT330780B (de) 1976-07-26
BG19806A3 (de) 1975-10-10
MC937A1 (fr) 1973-08-10

Similar Documents

Publication Publication Date Title
ES405663A1 (es) Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.
AU466296B2 (en) Enzyme compositions
ES388780A1 (es) Un metodo de preparacion de 1-(bencil sustituido) tetrahi- dro - 2 - (1h) - pirimidona util en la estimulacion del sis-tema nervioso central de animales y seres humanos.
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
AU461521B2 (en) Enzyme inhibitors of microbial origin
CA970692A (en) METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE
ES389371A1 (es) Procedimiento para la obtencion de derivados de 1-(1,3,4- tiadiazol-2-il)-imidazolidinona-(2).
ES392993A1 (es) Un procedimiento para la preparacion de nuevos compuestos de tetrazolo (1,5-a) quinoleina.
ES482598A1 (es) Un procedimiento para la preparacion de n-(diaminofosfinil) aril-carboxamidas.
ES391163A1 (es) Un procedimiento para la preparacion de guanidinas carbami-ladas y tiocarbamiladas.
ES389852A1 (es) Procedimiento de preparacion de nuevos derivados de indol.
ES418567A1 (es) Un procedimiento para preparar piridimidinas 5-(fenoxi sus-tituidas)-4-amino.
ES368721A1 (es) Procedimiento para la obtencion de derivados de ergopeptina.
GB1369874A (en) Stabilization of enzyme for lysing cells of dental-caries-inducing micro-organism
IT1016255B (it) Procedimento per l isolamento di 1.5 dinitroantrachinone
ES423716A1 (es) Procedimiento para la obtencion de 1,4-dihidroquinolinas.
CA922321A (en) Enzyme inhibitors
CA946837A (en) Enzyme inhibitor
IT8025518A0 (it) Procedimento per la produzione di acil-coa ossidasi.
CA1266268C (en) CARDIOTONIC AROYLTHIAZOLONES
ES446051A1 (es) Procedimiento para la preparacion de azabicicloalcanis y compuestos intermedios de los mismos.
CA946836A (en) Enzyme inhibitor
ES8107309A1 (es) Un procedimiento de produccion de derivados de 7 -metoxice- falosporina
ES396809A1 (es) Un procedimiento para la preparacion de los antipodas levo-giros.
CA609424A (en) Mosaic for forming lining or covering of furniture, walls or the like